Scientific American iPad App

Is Chronic Inflammation the Key to Unlocking the Mysteries of Cancer?

Understanding chronic inflammation, which contributes to heart disease, Alzheimer's and a variety of other ailments, may be a key to unlocking the mysteries of cancer















Editor's Note: This story, originally printed in the July 2007 issue of Scientific American, is being posted in light of two new studies showing that angiogenesis inhibitors, discussed in this article, may actually make tumors bigger, not smaller.

More than 500 million years ago a set of specialized enzymes and proteins evolved to defend our primitive ancestors against assaults from the outside world. If a microbe breached the shell of some Cambrian-era fauna, the members of this early vintage immune system would stage a savage but coordinated attack on these interlopers—punching holes in cell walls, spitting out chemical toxins or simply swallowing and digesting the enemy whole. Once the invaders were dispatched, the immune battalion would start to heal damaged cells, or if the attacked cells were too badly damaged it would put them to rest.

This inflammatory immune response worked so well that many aspects of it have been preserved during the protracted aeons of evolution. We know this to be true because studies have found that we share many of the same immune genes as the lowly fruit fly—and vertebrates and invertebrates diverged from a common ancestor in excess of half a billion years ago.

For years, immunology researchers have paid relatively little attention to this thuggish innate immune system, basically thinking of it as a crew of biochemical bouncers that pummel anything able to penetrate the tiniest opening in a living being’s skin or shell. They lavished their attention, instead, on the more advanced adaptive immune system, which can marshal antibodies and other weaponry that identify and then target an intruder with a specificity lacking in the untamed innate system.

In the past 15 years, innate immunity has come into its own. Inflammation, its hallmark characteristic, has gained recognition as an underlying contributor to virtually every chronic disease—a list that, besides obvious culprits such as rheumatoid arthritis and Crohn’s disease, includes diabetes and depression, along with major killers such as heart disease and stroke. The possibility of a link with a third major killer—cancer—has received intensive scrutiny in this decade. “The connection between inflammation and cancer has moved to center stage in the research arena,” notes Robert A. Weinberg of the Massachusetts Institute of Technology’s Whitehead Institute for Biomedical Research, who has highlighted the changing emphasis in a revision of his leading textbook, The Biology of Cancer (Garland Science, 2006).

This transformation recognizes that the immune inflammatory state serves as a key mediator of the middle stages of tumor development. Cancer begins with a series of genetic changes that prompt a group of cells to overreplicate and then invade surrounding tissue, the point at which true malignancy begins. Eventually some tumor cells may break off and establish new growths (metastases) at distant sites. That much has been understood for a long time. But cancer biologists and immunologists have begun to realize that the progression from diseased tissue to full-blown invasive cancer often requires cells that normally participate in healing cuts and scrapes to be diverted to the environs of the premalignant tissue, where they are hijacked to become co-conspirators that aid and abet carcinogenesis. As some researchers have described the malignant state: genetic damage is the match that lights the fire, and inflammation is the fuel that feeds it.

In this rewriting of the textbooks, a tumor is not just a clump of aberrant cells; it also includes a support system, a tumor microenvironment, which encompasses a multitude of varying immune cell types and crisscrossing chemical signals, along with a network of blood vessels. The tumor assumes the status of an outlaw organ that exists not to pump blood or rid the body of toxins but to serve only its own ends.



5 Comments

Add Comment
View
  1. 1. johnleb 04:06 AM 11/10/08

    This actually is not new news.. the theoretical model in Traditional Chinese Medicine ascribes the precursor to cancers as being "heat toxins" which can be loosely described as free radicals causing an inflammatory response in the body. A survey of herbal treatments for this condition may provide indicators for new pharmacologically active compounds that could prevent/protect the body from carcinogenic cellular growth

    Reply | Report Abuse | Link to this
  2. 2. LMcFarland 09:17 AM 11/11/08

    Many of the parasites which can colonise the human body influence our immune systems and dampen our inflammatory response to make us more hospitable hosts. I wonder are there any such organisms already producing their own ready-made pharmaceuticals which we could benefit from in this way to make us less susceptible to cancers and other inflammation-mediated disorders?

    Reply | Report Abuse | Link to this
  3. 3. ksaund 05:55 AM 6/8/09

    Many physicians believe that cellular inflammation is the basis for many of the common degenerative diseases that are impacting our population. With a host of information on anti-inflammatory supplements and diet guides, it just makes sense to pursue an anti-inflammatory lifestyle.

    Reply | Report Abuse | Link to this
  4. 4. Porcine aviator in reply to LMcFarland 02:04 PM 1/7/10

    There are indeed therapies based on helminths (hookworms) that offer promise. Sadly, however, this has not received much funding or media attention, likely because of the aversion of some to the idea of having living parasites in their body. The University of Iowa and Nottingham University in the UK have been two centers of study for helminth therapy.

    Hopefully soon helminth therapy will become more widely studied and available.

    Reply | Report Abuse | Link to this
  5. 5. tejaswi.iyyanki 01:41 PM 7/25/11

    Thank you for such a great summary of Chronic Inflammation in Cancer study. It is very use to take information from cross-disciplines and apply it to your research such as Tissue Engineering/Regenerating tissues. Interestingly macrophage polarization determines positive regeneration or chronic inflammation and some of the information obtained in cancer studies can be borrowed to regenerate tissues & organs.

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.
See what we're tweeting about

Scientific American Editors

Tweets could not be retrieved at this time

Free Newsletters


Get the best from Scientific American in your inbox

  SA Briefings

Latest from SA Blog Network

  SA Briefings

Science Jobs of the Week

Email this Article

Is Chronic Inflammation the Key to Unlocking the Mysteries of Cancer?

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X